Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Euronet Worldwide
EEFT
$2.92B
| $13.8M | 0.01% |
108,390
-42,544
| -28% | -$5.64M |
|
1652
Canadian Imperial Bank of Commerce
CM
$108B
| $13.8M | 0.01% |
247,514
-15,522
| -6% | -$894K |
|
|
FFAI
1653
Faraday Future Intelligent Electric
FFAI
$13.7M
| $13.8M | 0.01% |
+1
| New | +$16.5M |
|
1654
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
| $13.8M | 0.01% |
358,817
+283,453
| +376% | +$12.2M |
|
1655
Cognyte Software
CGNT
$647M
| $13.8M | 0.01% |
669,380
-284,321
| -30% | -$7.27M |
|
|
NOVA
1656
DELISTED
Sunnova Energy
NOVA
| $13.7M | 0.01% |
417,357
+169,720
| +69% | +$5.99M |
|
1657
Intellia Therapeutics
NTLA
$1.55B
| $13.7M | 0.01% |
102,267
-74,983
| -42% | -$11.4M |
|
1658
Smith & Wesson
SWBI
$669M
| $13.7M | 0.01% |
660,796
+261,844
| +66% | +$6.3M |
|
|
AAQC
1659
DELISTED
Accelerate Acquisition Corp
AAQC
| $13.7M | 0.01% |
1,409,219
+1,037,038
| +279% | +$10M |
|
1660
Qorvo
QRVO
$8.01B
| $13.7M | 0.01% |
82,006
+71,407
| +674% | +$13.3M |
|
1661
DigitalOcean
DOCN
$14.1B
| $13.7M | 0.01% |
176,557
+156,340
| +773% | +$9.66M |
|
|
AMED
1662
DELISTED
Amedisys
AMED
| $13.7M | 0.01% |
91,854
+17,315
| +23% | +$3.6M |
|
1663
Acushnet Holdings
GOLF
$5.88B
| $13.7M | 0.01% |
292,932
+33,881
| +13% | +$1.72M |
|
1664
Fidelity National Information Services
FIS
$23.8B
| $13.7M | 0.01% |
112,388
-79,317
| -41% | -$10.6M |
|
1665
CALL
Boston Scientific
BSX
$68.4B
| $13.7M | 0.01% |
314,900
-850,000
| -73% | -$37.6M |
|
1666
Kohl's
KSS
$2.21B
| $13.6M | 0.01% |
289,400
-1,304,665
| -82% | -$69.7M |
|
1667
PUT
Vanguard Real Estate ETF
VNQ
$39.4B
| $13.6M | 0.01% |
133,800
-65,100
| -33% | -$6.9M |
|
|
CCV
1668
DELISTED
Churchill Capital Corp V
CCV
| $13.6M | 0.01% |
1,390,756
-34,200
| -2% | -$337K |
|
1669
Radian Group
RDN
$5.16B
| $13.6M | 0.01% |
598,333
-379,416
| -39% | -$8.61M |
|
|
TWKS
1670
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $13.6M | 0.01% |
+473,065
| New | +$14M |
|
1671
Edwards Lifesciences
EW
$50B
| $13.6M | 0.01% |
119,821
-894,320
| -88% | -$102M |
|
1672
US Global Jets ETF
JETS
$786M
| $13.6M | 0.01% |
573,580
+368,555
| +180% | +$8.5M |
|
|
BLUA
1673
DELISTED
BlueRiver Acquisition Corp.
BLUA
| $13.5M | 0.01% |
1,388,337
+1,034,816
| +293% | +$10M |
|
1674
Arcosa
ACA
$7.13B
| $13.5M | 0.01% |
269,603
+153,671
| +133% | +$7.96M |
|
1675
Kulicke & Soffa
KLIC
$4.62B
| $13.5M | 0.01% |
+231,978
| New | +$14.4M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.